MapLight Therapeutics, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2023 | — | $-117.6M | — |
| Mar 2024 | — | $-136.0M | — |
| Jun 2024 | — | $-154.3M | — |
| Sep 2024 | — | $-172.4M | — |
| Dec 2024 | — | $-193.6M | $38.3M |
| Mar 2025 | — | $-215.8M | — |
| Jun 2025 | — | $-245.1M | — |
| Sep 2025 | — | $-274.2M | $64.1M |
| Dec 2025 | — | $458.4M | $46.7M |
| Mar 2026 | — | $399.8M | $55.7M |
| Jun 2026 | — | $348.3M | $71.6M |